European Council - Statement of the Members of the European Council

25 March 2021 |

COVID-19
Accelerating the production, delivery and deployment of vaccines remains essential and urgent to overcome the crisis. Efforts to this end must be further intensified. We underline the importance of transparency as well as of the use of export authorisations. We recognise the importance of global value chains and reaffirm that companies must ensure predictability oftheir vaccine production and respect contractual delivery deadlines. We confirm the pro-ratapopulation key for the allocation of vaccines. We invite the Committee of Permanent Representatives to address the issue of the speed of deliveries of vaccines when allocating the 10 million BioNTech-Pfizer accelerated doses in the second quarter of 2021 in a spirit of solidarity.

Read more at the file below.

RELATED FILES

About Us
Profile
Board of Directors
Stakeholder Network
Contact

LOGIN